Exploring the role of esketamine in alleviating depressive symptoms in mice via the PGC-1α/irisin/ERK1/2 signaling pathwayNa Hu(Affiliated Hospital of Southwest Medical University), Xiaobin Wang(Southwest Medical University)Scientific ReportsOctober 3, 202310.1038/s41598-023-43684-9Cited by 9SaveCiteExport RISWatch citationsRelated PapersKetamine ameliorates depressive-like behaviors in mice through increasing glucose uptake regulated by the ERK/GLUT3 signaling pathway|Scientific Reports|2021|28